According to the complaint, PillPack would dispense and bill for a full carton of insulin pens and falsely underreport the days of supply. (Photo: Daniel Beckemeier/Shutterstock.com)
The United States has settled a health care fraud lawsuit against online retail pharmacy PillPack LLC, a wholly owned subsidiary of Amazon.com Inc. The move resolves allegations that PillPack improperly billed government health care programs — including Medicare and Medicaid — for more insulin pens than patients needed based on their prescriptions and falsely under-reported the "days of supply" of insulin dispensed.
Damian Williams, the United States Attorney for the Southern District of New York, and Scott J. Lampert, Special Agent-in-Charge of the U.S. Department of Health and Human Services Office of the Inspector General New York Regional Office, made the joint announcement May 2.
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
